ZA959510B - Novel crystalline cephem acid addition salts and processes for their preparation - Google Patents
Novel crystalline cephem acid addition salts and processes for their preparationInfo
- Publication number
- ZA959510B ZA959510B ZA959510A ZA959510A ZA959510B ZA 959510 B ZA959510 B ZA 959510B ZA 959510 A ZA959510 A ZA 959510A ZA 959510 A ZA959510 A ZA 959510A ZA 959510 B ZA959510 B ZA 959510B
- Authority
- ZA
- South Africa
- Prior art keywords
- processes
- preparation
- acid addition
- addition salts
- novel crystalline
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D501/14—Compounds having a nitrogen atom directly attached in position 7
- C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
- C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
- C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
- C07D501/48—Methylene radicals, substituted by hetero rings
- C07D501/56—Methylene radicals, substituted by hetero rings with the 7-amino radical acylated by carboxylic acids containing hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Cephalosporin Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4440141A DE4440141A1 (de) | 1994-11-10 | 1994-11-10 | Neue kristalline Cephem-Säureadditionssalze und Verfahren zu ihrer Herstellung |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA959510B true ZA959510B (en) | 1996-05-28 |
Family
ID=6532953
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA959510A ZA959510B (en) | 1994-11-10 | 1995-11-09 | Novel crystalline cephem acid addition salts and processes for their preparation |
Country Status (28)
Country | Link |
---|---|
US (1) | US5747484A (fr) |
EP (1) | EP0711774B1 (fr) |
JP (1) | JP3920939B2 (fr) |
KR (1) | KR100449191B1 (fr) |
CN (1) | CN1066452C (fr) |
AR (1) | AR002246A1 (fr) |
AT (1) | ATE213248T1 (fr) |
AU (1) | AU707730B2 (fr) |
BR (1) | BR9505132A (fr) |
CA (1) | CA2162530C (fr) |
CZ (1) | CZ290936B6 (fr) |
DE (2) | DE4440141A1 (fr) |
DK (1) | DK0711774T3 (fr) |
ES (1) | ES2172549T3 (fr) |
FI (1) | FI120263B (fr) |
HU (1) | HU219475B (fr) |
IL (1) | IL115914A (fr) |
MA (1) | MA23709A1 (fr) |
NO (1) | NO311891B1 (fr) |
NZ (1) | NZ280424A (fr) |
OA (1) | OA10242A (fr) |
PL (1) | PL182806B1 (fr) |
PT (1) | PT711774E (fr) |
RU (1) | RU2161619C2 (fr) |
SK (1) | SK282545B6 (fr) |
TR (1) | TR199501392A2 (fr) |
TW (1) | TW422847B (fr) |
ZA (1) | ZA959510B (fr) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998049130A2 (fr) * | 1997-04-29 | 1998-11-05 | The University Of New Mexico | Acides hydroxynaphtoiques et derives de ces derniers |
CA2501395C (fr) * | 2002-10-25 | 2011-05-24 | Akzo Nobel Nv | Composition pharmaceutique a liberation prolongee |
US20080318919A1 (en) * | 2005-10-29 | 2008-12-25 | Intervet International B.V. | Cefquinome Compositions and Methods of Their Use |
AR077320A1 (es) * | 2009-07-20 | 2011-08-17 | Intervet Int Bv | Metodo para la preparacion de particulas de cefquinoma y formulaciones farmaceuticas que las comprenden. |
EP2862569A1 (fr) | 2011-09-09 | 2015-04-22 | Cubist Pharmaceuticals, Inc. | Procédés pour traiter des infections intrapulmonaires |
EP2750706A4 (fr) * | 2011-09-29 | 2015-04-15 | Alere San Diego Inc | Analogues d'acide 2-hydroxyhippurique et procédés pour leurs synthèses et utilisation |
US8809314B1 (en) | 2012-09-07 | 2014-08-19 | Cubist Pharmacueticals, Inc. | Cephalosporin compound |
US8476425B1 (en) | 2012-09-27 | 2013-07-02 | Cubist Pharmaceuticals, Inc. | Tazobactam arginine compositions |
US9320740B2 (en) | 2013-03-15 | 2016-04-26 | Merck Sharp & Dohme Corp. | Ceftolozane-tazobactam pharmaceutical compositions |
US9872906B2 (en) | 2013-03-15 | 2018-01-23 | Merck Sharp & Dohme Corp. | Ceftolozane antibiotic compositions |
KR102226197B1 (ko) | 2013-03-15 | 2021-03-11 | 머크 샤프 앤드 돔 코포레이션 | 세프톨로잔 항균성 조성물 |
WO2015035376A2 (fr) | 2013-09-09 | 2015-03-12 | Calixa Therapeutics, Inc. | Traitement d'infections au moyen de ceftolozane/tazobactam chez des sujets ayant une fonction rénale altérée |
US20150094293A1 (en) | 2013-09-27 | 2015-04-02 | Calixa Therapeutics, Inc. | Solid forms of ceftolozane |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3118732A1 (de) * | 1981-05-12 | 1982-12-02 | Hoechst Ag, 6000 Frankfurt | Cephalosporinderivate und verfahren zu ihrer herstellung |
DE3248281A1 (de) * | 1982-12-28 | 1984-06-28 | Hoechst Ag, 6230 Frankfurt | Kristalisierte cephem-saeureadditionssalze und verfahren zu ihrer herstellung |
DE3316797A1 (de) * | 1983-05-07 | 1984-11-08 | Hoechst Ag, 6230 Frankfurt | Verfahren zur herstellung von cephemverbindungen |
DE3706020A1 (de) * | 1987-02-25 | 1988-09-08 | Hoechst Ag | Kristallisierte cephem-saeureadditionssalze und verfahren zu ihrer herstellung |
-
1994
- 1994-11-10 DE DE4440141A patent/DE4440141A1/de not_active Withdrawn
-
1995
- 1995-10-27 TW TW084111318A patent/TW422847B/zh not_active IP Right Cessation
- 1995-11-01 MA MA24054A patent/MA23709A1/fr unknown
- 1995-11-01 US US08/551,480 patent/US5747484A/en not_active Expired - Lifetime
- 1995-11-06 ES ES95117409T patent/ES2172549T3/es not_active Expired - Lifetime
- 1995-11-06 AT AT95117409T patent/ATE213248T1/de active
- 1995-11-06 DK DK95117409T patent/DK0711774T3/da active
- 1995-11-06 DE DE59510048T patent/DE59510048D1/de not_active Expired - Lifetime
- 1995-11-06 PT PT95117409T patent/PT711774E/pt unknown
- 1995-11-06 EP EP95117409A patent/EP0711774B1/fr not_active Expired - Lifetime
- 1995-11-08 SK SK1397-95A patent/SK282545B6/sk not_active IP Right Cessation
- 1995-11-08 IL IL11591495A patent/IL115914A/en not_active IP Right Cessation
- 1995-11-08 NZ NZ280424A patent/NZ280424A/en not_active IP Right Cessation
- 1995-11-08 FI FI955382A patent/FI120263B/fi not_active IP Right Cessation
- 1995-11-08 TR TR95/01392A patent/TR199501392A2/xx unknown
- 1995-11-08 CN CN95118555A patent/CN1066452C/zh not_active Expired - Lifetime
- 1995-11-08 AR ARP950100095A patent/AR002246A1/es unknown
- 1995-11-08 AU AU37728/95A patent/AU707730B2/en not_active Expired
- 1995-11-08 CZ CZ19952933A patent/CZ290936B6/cs not_active IP Right Cessation
- 1995-11-09 RU RU95119433/04A patent/RU2161619C2/ru active
- 1995-11-09 CA CA002162530A patent/CA2162530C/fr not_active Expired - Lifetime
- 1995-11-09 NO NO19954511A patent/NO311891B1/no not_active IP Right Cessation
- 1995-11-09 ZA ZA959510A patent/ZA959510B/xx unknown
- 1995-11-09 PL PL95311326A patent/PL182806B1/pl unknown
- 1995-11-09 KR KR1019950040388A patent/KR100449191B1/ko not_active IP Right Cessation
- 1995-11-09 JP JP29142795A patent/JP3920939B2/ja not_active Expired - Lifetime
- 1995-11-09 HU HU9503213A patent/HU219475B/hu unknown
- 1995-11-09 BR BR9505132A patent/BR9505132A/pt not_active IP Right Cessation
- 1995-11-10 OA OA60734A patent/OA10242A/fr unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR987000253A (en) | Crystallization of adipic acid | |
IL115914A0 (en) | Novel crystalline cephem acid addition salts and processes for their preparation | |
AP9400705A0 (en) | Crystalline N-acetyl neuraminic acid derivatives and processes for their preparation | |
HU9602128D0 (en) | Process for the preparation of a salt of clavulanic acid | |
IL105100A0 (en) | Glutamic acid derivatives and process for their preparation | |
GR3017917T3 (en) | Crystalline addition salts of cephem compounds and process for their preparation. | |
HUP0102124A3 (en) | Process for preparing 2-acetylthio-3-phenyl-propionic acid and the salts thereof | |
ZA9510880B (en) | Clavulanic acid salts | |
IL112323A0 (en) | Process and intermediates for preparing naphthyridonecarboxylic acid salts | |
IL102071A0 (en) | Microbiological process for the preparation of 5-hydroxypyrazinoic acid | |
GB9409395D0 (en) | Sialic acid derivatives and process for their preparation | |
GR3033714T3 (en) | Process for the preparation of o-chloro-methyl-phenylglyoxylic acid derivatives | |
IL129408A0 (en) | Cephalosporin crystals and process for their preparation | |
IL111183A0 (en) | Process for the preparation of 5-fluoroanthranilic acid | |
AU6495298A (en) | Process for preparing 3-hydroxy-3-methylbutyric acid or its salts | |
IL108134A0 (en) | Cephalosporin salts and process for the preparation thereof | |
AU1556995A (en) | Process for making 5-nitrobarbituric acid and salts thereof | |
EP0453022A3 (en) | Method for the purification of benzoic acid | |
HU9601278D0 (en) | Process for the preparation of 2-fluorcyclopropylamine sulphonic acid salts and 2-fluorcyclopropylisocyanates | |
IL108884A0 (en) | Process for the preparation of p-fluoro-alpha-met hyl-cinnamic acid derivatives | |
GB9411194D0 (en) | Clavulanic acid salt | |
IL111283A0 (en) | Process for the preparation of 3-hydroxybenzoic acid | |
AU7315398A (en) | An intermediate for preparing naphthyridonecarboxylic acid salts | |
IL128881A0 (en) | Process for preparing benzoic acid derivatives | |
HU9402707D0 (en) | Phtalimidic acid and salts |